OSCR Stock Pops Pre-Market On Record Quarterly Income – Retail Traders Say ‘Still Undervalued’ Even At $30

• Oscar Health reaffirmed its outlook for full year 2026, with revenue in the range of $18.7 billion - $19 billion.
• Oscar Health’s total members as of March 31, 2026, stood at roughly 3.2 million, a 55% increase from the end of March last year.
• The insurer’s medical loss ratio improved to 70.5% from 75.4% last year.

Shares of Oscar Health (OSCR) jumped more than 11% in pre-market trading on Wednesday, as investors cheered the insurer’s biggest-ever quarterly profit and a first earnings beat in four quarters, powered by strong membership growth.

OSCR stock is tracking its highest levels in more than six months.

OSCR’s Q1 EPS Smashes Estimates

Oscar Health’s first-quarter (Q1) revenue surged more than 52% to $4.65 billion, though it fell short of Wall Street’s estimates of $4.92 billion, according to Fiscal.ai data. Net income soared 146% to $679 million, or 2.07 per share, far exceeding consensus estimates of $1.1 per share.

Profitability also strengthened, as the medical loss ratio improved to 70.5% from 75.4%, supported by disciplined pricing and favorable claims trends. The metric is crucial for insurers as it represents the share of revenue spent on medical claims. A higher ratio indicates that costs are rising faster than revenue. This came in better than peer UnitedHealth’s (UNH) 83.9% in Q1.

Oscar Health also reaffirmed its outlook for full year (FY) 2026, with revenue in the range of $18.7 billion - $19 billion, MLR between 82.4% and 83.4%, and earnings from operations between $250 million and $450 million.

What Drove OSCR’s Q1 Results?

Oscar Health’s total members as of March 31, 2026, stood at roughly 3.2 million, a 55% increase from the end of March last year.

This exceeded CEO Mark Bertolini’s expectations. During the earnings call last quarter, Bertolini said the company expects around 3 million paid members by the start of the second quarter (Q2) of FY2026.

“We expect to start the second quarter with approximately 3 million paid members, a 58% increase year over year.”

Retail Says ‘OSCR At $30’ Would Still Be Undervalued

Retail sentiment on Stocktwits flipped to ‘bullish’ from ‘bearish’ a day earlier, amid ‘high’ message volumes.

One bullish user said Oscar Health is a tech-driven healthcare platform that benefits from the shift to personalized care.

Another user said the stock would be considered undervalued even if it hit $30. It is currently trading just above $19.

The stock has gained nearly 23% so far this year.

Read also: This Small-Cap Biotech Stock Is Tracking A Crucial Bullish Technical Milestone – And Retail Traders Are Taking Notice

For updates and corrections, email newsroom[at]stocktwits[dot]com.